Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Discovery of a novel MAb able to inhibit sporozoite invasion of hepatocytes in vivo

Dec. 4, 2014

Phase I results reported for glioma vaccine SurVaxM

Dec. 4, 2014

Novel CDK4/6 inhibitor is active in models of rheumatoid arthritis

Dec. 4, 2014

Phase I data presented for CC-220 as treatment for SLE and other autoimmune diseases

Dec. 3, 2014

Phase I results for recombinant ApoA-I Milano/phospholipid complex as treatment of atherosclerosis

Dec. 3, 2014

Homologous recombination deficiency score can predict response to niraparib in ovarian cancer

Dec. 3, 2014

RaQualia presents preclinical findings on novel TRPM8 antagonists for neuropathic pain

Dec. 3, 2014

Compound inhibiting SSAO may improve Parkinson's disease

Dec. 2, 2014

GlaxoSmithKline presents preclinical data for the anti-HER3 antibody GSK-2849330

Dec. 2, 2014

Icosabutate shows promise as lipid-lowering agent in animal studies and early clinical trials

Dec. 2, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...